Sm-logo-resized.jpg.png
Oncology Drugs Market Worth $848.94 Billion by 2030 at 9.51 % CAGR
August 29, 2022 14:37 ET | STRATEGIC MARKET RESEARCH LLP
New York,USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Oncology Drugs Market Worth $848.94 Billion by 2030 at 9.51 % CAGR The revenue of the Oncology Drugs Market was USD 177.54 Billion in 2021 and is...
22157.jpg
Global Biopharmaceutical Contract Manufacturing Markets Outlook & Forecast 2022-2027 Featuring Key Vendors - Boehringer Ingelheim, Lonza, Samsung Biologics
August 29, 2022 08:18 ET | Research and Markets
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering....
Future Market Insights.png
Antibodies Market is Forecast to Reach a Valuation of US$ 601.614 Billion by the end of 2031 | Future Market Insights, Inc. NEWARK, Del, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Future Market Insights, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in...
Kenneth Research Logo.png
Global Monoclonal Antibodies (MABs) Market to Garner Around USD 450 Billion in 2031 and to Grow with a CAGR of ~14% During 2022-2031; Rising Incidence of Cancer to Steer Bright Market Growth
August 17, 2022 08:34 ET | Kenneth Research
New York, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has released a thorough market study on the ‘Global Monoclonal Antibodies MABs Market’ for the forecast period, i.e., 2022-2031 that...
22157.jpg
Monoclonal Antibody Industry Deals & Agreements, 2015 to 2022 - Access to 1,000+ Monoclonal Antibodies Deal Records, and the Leading Deals by Value Since 2015
August 16, 2022 07:53 ET | Research and Markets
Dublin, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global...
Chinese Infliximab Market
China Infliximab Market Investigation Report 2022: Sales 2017-2021, Major Manufacturers 2017-2021, Prices for Different Manufacturers 2021-2022 and Prospects 2022-2031
August 10, 2022 05:28 ET | Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2022-2031" report has been added to ResearchAndMarkets.com's offering. According to this market...
22157.jpg
Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies Bundle Report 2022: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis
August 09, 2022 06:18 ET | Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and...
Global Cancer Immunotherapy Market
Global Cancer Immunotherapy Market to Reach $90.53 Billion by 2027
August 09, 2022 05:13 ET | Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Immunotherapy Market (2022-2027) by Product, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with...
22157.jpg
Global Cancer Therapies Market Analysis Report 2022-2026: Chemotherapy & Targeted Therapy Lead the Global Cancer Therapies Market
August 05, 2022 06:08 ET | Research and Markets
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Cancer Therapies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cancer Therapies Market...
Biotechnology Market
Global Biotechnology Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
August 02, 2022 07:38 ET | Research and Markets
Dublin, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The "Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...